Screening for chronic Q-fever is only cost-effective for specific groups RIVM has investigated for which groups screening for chronic Q-fever might be cost-effective.
Pneumococcal disease in the elderly The Health Council of the Netherlands is preparing an advice on pneumococcal vaccination for the elderly on request of the Ministry of Health, Welfare and Sport.
Statement on health care spending Down syndrome Recently a tweet containing a video from a Dutch tv-show about Down syndrome caused a lot of turmoil on Twitter.
Temporary dermal fillers prove harmless RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.
Slight increase of the number of tuberculosis patients in 2016 For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.
Promising biobased alternatives to controversial polar aprotic solvents There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .
Construction officially starts on new accommodations for VWS / RIVM and CBG Hugo de Jonge, Dutch Minister of Health, Welfare and Sport, marked the official start of construction on the new accommodations for RIVM and for the Medicines Evaluation Board (CBG).
A critical look at the European Union Observatory for Nanomaterials On 14 June 2017, the European Commission launched the “European Union Observatory for Nanomaterials” (EUON). As registration is not mandatory, the EUON is limited in detailed information.
European critical loads: database, biodiversity and ecosystems at risk Approximately 79 percent of the nature reserves (Natura 2000 areas) in EU countries are estimated to be exposed to an excess of nitrogen deposition in 2020.
80 ways to a more sustainable future: INHERIT Promising Practices Database Learn what others are doing to make lifestyles more sustainable!